Andreas Emmenegger

Andreas Emmenegger is an accomplished finance executive with extensive experience across various sectors, primarily biotechnology and banking. Currently serving as the Group CFO and Group CBO at Swiss Rockets AG since September 2024, Andreas has also held significant roles such as a Member of the Board of Directors at Luzerner Kantonalbank since May 2016, where responsibilities include chairing the audit and finance committee. Previous positions include Chief Financial Officer at Owkin and a long tenure at Molecular Partners AG, where Andreas was a founding investor and instrumental in raising approximately $500 million through multiple equity financing rounds and overseeing the company's IPOs. Additional experience encompasses co-founding PIQUR Therapeutics AG and serving as CFO for several companies including Glycart Biotechnology AG and The Fantastic Corporation, alongside a strong educational background with degrees from institutions like IESE Business School and Stanford University.